Asensus Surgical Inc. (ASXC): Price and Financial Metrics
GET POWR RATINGS... FREE!
ASXC Stock Price Chart Interactive Chart >
ASXC Price/Volume Stats
|Current price||$2.34||52-week high||$6.95|
|Prev. close||$2.30||52-week low||$0.32|
|Day high||$2.38||Avg. volume||20,469,674|
|50-day MA||$2.76||Dividend yield||N/A|
|200-day MA||$2.29||Market Cap||545.66M|
Asensus Surgical Inc. (ASXC) Company Bio
Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, economic shortcomings in surgery. The Senhance Surgical System features as the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.
ASXC Latest News Stream
|Loading, please wait...|
ASXC Latest Social Stream
View Full ASXC Social Stream
Latest ASXC News From Around the Web
Below are the latest news stories about Asensus Surgical Inc that investors may wish to consider to help them evaluate ASXC as an investment opportunity.
RESEARCH TRIANGLE PARK, N.C., July 28, 2021--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced that it has received FDA 510(k) clearance for 5 mm diameter articulating instruments, adding to the Senhance Surgical System technology platform. Articulating instruments offer better access to difficult-to-reach areas of the anatomy by providing two
RESEARCH TRIANGLE PARK, N.C., July 26, 2021--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing two new board members, Elizabeth Kwo, MD and Kevin Hobert, effective immediately.
Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 5, 2021
RESEARCH TRIANGLE PARK, N.C., July 22, 2021--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2021 second quarter financial and operating results after the market closes on Thursday, August 5, 2021. The Company will host a conference call to discuss these results starting at 4:30 p.m. ET the same day. The call will be
Asensus Surgical (ASXC) Presents At Ladenburg Thalmann 2021 Virtual Healthcare Conference - Slideshow
The following slide deck was published by Asensus Surgical, Inc. in conjunction with this event....
Asensus Surgical (ASXC) has filed a 510(k) submission with the FDA for an expansion of capabilities on the previously cleared Intelligent Surgical Unit ((ISU)).The ISU is utilized on the Company’s Senhance Surgical System which enables digital laparoscopy. The current features of the ISU enable machine vision driven control of the...
ASXC Price Returns